id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-322867-1yxxe5d3	Hartman, William R	Hospitalized COVID-19 Patients treated with Convalescent Plasma in a Mid-size City in the Midwest	2020-07-14		.txt	text/plain	2901	150	50	Methods: Hospitalized COVID-19 patients categorized as having Severe or Life-Threatening disease according to the Mayo Clinic Emergency Access Protocol were screened, consented, and treated with convalescent plasma collected from local donors recovered from COVID-19 infection. Among patients who were admitted with infection that met the criteria for severe disease and were transfused convalescent plasma prior to the development of respiratory failure the mortality to date is zero, and only one patient (6%) has had subsequent escalation of respiratory failure requiring mechanical ventilation. A recent cohort study by Liu and colleagues of 39 cases and 156 matched controls from Mount Sinai hospital in New York City reported a 12.8% mortality rate among patients with severe or worse disease who received convalescent plasma, and signi cantly better outcomes among patients transfused prior to mechanical ventilation. Inpatient respiratory support type by hospital day among COVID-19 patients with life-threatening disease receiving convalescent plasma (n = 15).	./cache/cord-322867-1yxxe5d3.txt	./txt/cord-322867-1yxxe5d3.txt